Table 3 Patient characteristics by courses with and without ductus closure.

From: Response of the ductus arteriosus to acetaminophen or indomethacin in extremely low birth weight infants

 

PDA Closed (n = 23)

PDA Not Closed (n = 113)

p value

GA at birth, weeks (median, IQR)

25 [24–26]

25 [24–26]

0.83

Birth weight, grams (median, IQR)

730 [612–855]

710 [590–870]

0.9

Female

13 (57%)

76 (67%)

0.32

Cesarean delivery

20 (87%)

92 (81%)

0.53

IUGR present

8 (35%)

33 (29%)

0.59

Inborn delivery

16 (70%)

81 (72%)

0.84

Race

 African American

7 (30%)

38 (34%)

0.45

 African American/White

1 (4%)

2 (2%)

 Asian

1 (4%)

7 (6%)

 Asian/White

1 (4%)

1 (1%)

 Hispanic/Latin

0 (0%)

1 (1%)

 Hispanic/Latino

1 (4%)

0 (0%)

 Unknown

1 (4%)

6 (5%)

 White

11 (48%)

58 (51%)

Apgar score (median, IQR)

 1 min

2 [1–6]

3 [1–6]

0.84

 5 min

7 [5–7]

6.5 [4.0–8.0]

0.77

 10 min

7.0 [6.2–7.8]

7.0 [6.0–7.0]

0.71

Vasopressor requirementa, n

4 (17%)

7 (6%)

0.073

 VISMAX (median, IQR)

5.5 [5-6.25]

5 [5–10]

---

Respiratory support typea, n

  

---

 Mechanical ventilation

13

69

 

 CPAP

10

42

 

 High flow nasal cannula

0

2

 

RSSMVa,b (median, IQR)

3.7 [2.9–5.3]

3.4 [2.7–5.0]

0.42

RSSCPAPa,c (median, IQR)

1.3 [1.1–1.4]

1.4 [1.1–1.6]

0.41

Intravenous Acetaminophen

11/15 (73%)

60/77 (78%)

0.7

Enteral Acetaminophen

8/15 (53%)

25/77 (32%)

0.12

Age at therapy start, days (median, IQR)

12 [7.5–16.5]

13 [8.0–19.0]

0.58

Age < 14 days at starta

13 (57%)

60 (53%)

0.76

  1. aOn day of PDA therapy start.
  2. bRSSMV = (median FiO2 x median MAP)/100.
  3. cRSSCPAP = (median PEEP x median FiO2)/100.